AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Advancements in Tau-Targeting Therapies for Alzheimer's Disease
Exploring the successful reduction of Tau messenger RNA and protein levels, leading to the progression of Voyager Therapeutics' research program for Alzheimer's disease. The chapter showcases hopeful prospects for enhancing clinical outcomes in patients with Alzheimer's.